Last updated: May 27, 2015
Sponsor: University of Erlangen-Nürnberg Medical School
Overall Status: Terminated
Phase
3
Condition
Coronary Artery Disease
Hypercholesterolemia
Atherosclerosis
Treatment
N/AClinical Study ID
NCT00663104
OFZ-Trace
Ages 45-55 Female Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
1-3 years early postmenopausal
Caucasian race
Exclusion
Exclusion Criteria:
CHD-diseases
thrombosis, embolism
fractures at lumbar spine or hip
secondary osteoporosis
hyperparathyroidism
medication, diseases with impact on muscle or bone
cancer and hormone derived malign diseases
weight reduction of > 5 kg during the last 6 months
Study Design
Total Participants: 126
Study Start date:
April 01, 2008
Estimated Completion Date:
November 30, 2009
Connect with a study center
Institute of Medical Physics
Erlangen, 91052
GermanySite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.